PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential
Open Access
Abstract
Thyroid cancer (TC) is an endocrine malignant tumor with the fastest-growing incidence worldwide. It has complex pathological types and significant heterogeneity, with great differences in clinical prognosis among different subtypes. Among them, aggressive subtypes, such as radioiodine-refractory (RAI-R) TC and anaplastic thyroid cancer (ATC), have become a major challenge in current clinical diagnosis and treatment, due to limited treatment options and high risks of recurrence and metastasis. Tumor metabolic reprogramming is one of the characteristics of cancer, among which the Warburg effect plays a driving role. As a rate-limiting enzyme in the glycolytic pathway, pyruvate kinase M2 (PKM2), with its unique functional plasticity, has become a linchpin of glycolytic metabolism and malignant phenotypes of tumor cells. This article will systematically review the functional regulatory mechanisms of PKM2, its specific role in TC, and explore the targeted therapeutic strategies and research prospects of TC with PKM2, providing a new theoretical basis and potential plans for the clinical diagnosis and treatment.Keywords
Funding Information
- Shanghai Innovation Medical Device Application Demonstration Project 2023 (23SHS05200)
- Zhongshan Hospital (2025XKPT58)
- Zhongshan Hospital (2025XKPT58-1)
This publication has 155 references indexed in Scilit:
- An update on redifferentiation strategies for radioactive iodine-refractory differentiated thyroid carcinomaEndocrine, 2024
- Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancerEndocrine, 2024
- Thyroid CancerJAMA, 2024
- HIF‐1α regulates the cell viability in radioiodine‐resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF‐κB signaling pathwayMolecular Carcinogenesis, 2023
- Risk factors for death of follicular thyroid carcinoma: a systematic review and meta-analysisEndocrine, 2023
- Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional ExperienceEndocrine Pathology, 2023
- The enhancement of glycolysis regulates pancreatic cancer metastasisCellular and Molecular Life Sciences, 2019
- An overview of structure, function, and regulation of pyruvate kinasesProtein Science, 2019
- Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid CancerJAMA, 2013
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002